These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 36526047)
1. Effect of folate-targeted Erlotinib loaded human serum albumin nanoparticles on tumor size and survival rate in a rat model of glioblastoma. Kamali M; Webster TJ; Amani A; Hadjighassem MR; Malekpour MR; Tirgar F; Khosravani M; Adabi M Life Sci; 2023 Jan; 313():121248. PubMed ID: 36526047 [TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells. Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429 [TBL] [Abstract][Full Text] [Related]
3. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles. Akbarian A; Ebtekar M; Pakravan N; Hassan ZM Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865 [TBL] [Abstract][Full Text] [Related]
4. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364 [TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab. Pang J; Xing H; Sun Y; Feng S; Wang S Biomed Pharmacother; 2020 May; 125():109861. PubMed ID: 32070872 [TBL] [Abstract][Full Text] [Related]
6. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment. Shen Y; Li W Drug Des Devel Ther; 2018; 12():2285-2292. PubMed ID: 30087553 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting. Wang W; Liang H; Sun B; Xu J; Zeng Z; Zhao X; Li Q J Pharm Sci; 2016 Jun; 105(6):1874-1880. PubMed ID: 27129905 [TBL] [Abstract][Full Text] [Related]
8. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors. Lian B; Wu M; Feng Z; Deng Y; Zhong C; Zhao X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):154-165. PubMed ID: 30686050 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib. Yin N; Yu H; Zhang X; Lv X Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890 [TBL] [Abstract][Full Text] [Related]
10. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma. Emamgholizadeh Minaei S; Khoei S; Khoee S; Karimi MR Int J Biochem Cell Biol; 2019 Mar; 108():72-83. PubMed ID: 30660689 [TBL] [Abstract][Full Text] [Related]
11. Design of fluorophore-loaded human serum albumin nanoparticles for specific targeting of NIH:OVCAR3 ovarian cancer cells. Borlan R; Tatar AS; Soritau O; Maniu D; Marc G; Florea A; Focsan M; Astilean S Nanotechnology; 2020 Jul; 31(31):315102. PubMed ID: 32315999 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308 [TBL] [Abstract][Full Text] [Related]
13. Folate Decorated Multifunctional Biodegradable Nanoparticles for Gastric Carcinoma Active Targeting Theranostics. Zhang X; Yan R; Wei Z; Yang D; Hu Z; Zhang Y; Huang X; Huang H; Wang W Int J Nanomedicine; 2022; 17():2493-2502. PubMed ID: 35669001 [TBL] [Abstract][Full Text] [Related]
14. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability. Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138 [TBL] [Abstract][Full Text] [Related]
15. Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment. Kunjiappan S; Govindaraj S; Parasuraman P; Sankaranarayanan M; Arunachalam S; Palanisamy P; Mohan UP; Babkiewicz E; Maszczyk P; Vellaisamy S; Panneerselvam T Nanotechnology; 2020 Apr; 31(15):155102. PubMed ID: 31775133 [TBL] [Abstract][Full Text] [Related]
16. Human serum albumin-poly(Lactide)-conjugated self-assembly NPs for targeted docetaxel delivery and improved therapeutic efficacy in oral cancer. Kumbham S; Ghosh A; Ghosh B; Biswas S Int J Biol Macromol; 2022 Dec; 222(Pt A):1287-1303. PubMed ID: 36191788 [TBL] [Abstract][Full Text] [Related]
17. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid. Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer. Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555 [TBL] [Abstract][Full Text] [Related]
19. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery. Wu T; Gong Y; Li Z; Li Y; Xiong X Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742 [TBL] [Abstract][Full Text] [Related]
20. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells. Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]